Bio PRs. CEL-SCI's Price Rebound Looks Stron

Bio PRs.

• CEL-SCI's Price Rebound Looks Strong
  7:01 am - Marketwire


• Phoenix Plastic Surgeon Uses Fat Injections to Provide Fullness and Volume to Face and Breasts
  7:01 am - Marketwire


• CollabRx and OncoDNA Partner in Molecular Diagnostics
  7:01 am - GlobeNewswire


• NewLink Genetics Presents Preclinical Data on NLG919, a New Drug Candidate from a Novel Class of IDO Pathway Inhibitors for the Treatment of Cancer
  7:00 am - PR Newswire


• Catamaran's BriovaRx Receives URAC Specialty Pharmacy Accreditation
  7:00 am - CNW Group


• Emergent BioSolutions to Release First Quarter 2013 Financial Results and Conduct a Conference Call on May 2, 2013
  7:00 am - Business Wire


• Cyclacel Announces Sale of Four Cyclacel Romidepsin-Related Patents to Celgene and Dismissal of All Claims in Their Patent Litigation
  7:00 am - GlobeNewswire


• Foundation Medicine and Agios Announce Diagnostic Discovery Collaboration for IDH1 and IDH2 Cancer Metabolism Programs
  7:00 am - Business Wire


• ManageEngine: BMI Healthcare Improves Visibility and Security of Devices Accessing the Central Network While Boasting Savings of 70% in IT Expenditure
  6:37 am - Business Wire


• Research and Markets: Antibody Technologies and Attrition Rates - an industry analysis 2013
  6:32 am - Business Wire


• VolitionRx Files Two Patent Applications
  6:30 am - PR Newswire


• Illumina Launches TruSight™ Tumor Content Set
  6:30 am - Business Wire


• Battle to Protect Premiere Skin Care Line In Full Throttle; ZO Skin Health, Inc. Files John Doe Claim; Subpoenas 20 Major Websites
  6:23 am - PR Newswire


• It's LIVE! 2013 North American Pharmaceutical & Biotech Industry Outlook Spotlights $15 Billion in Capital Spending, an Industrial Info News Alert
  6:15 am - Marketwire


• Aerocrine: Notice of Annual General Meeting
  6:14 am - Business Wire


• Aerocrine: Proposals to the Annual General Meeting 2013 on a Board member share plan and amendment to the 2011 employee option program
  6:08 am - Business Wire


• Research and Markets: Arthritis - Pipeline Review, H1 2013
  6:03 am - Business Wire


• Male Plastic Surgery Now Represents 25-30% of Chicago Practice's Patients
  6:01 am - Marketwire


• Dallas Plastic Surgeon Participates in Rhinoplasty Case Studies Panel
  6:01 am - Marketwire


• Research and Markets: Autoimmune Disorders - Pipeline Review, H1 2013
  6:01 am - Business Wire


• Take Care Clinics Expand Scope of Health Care Services to Include Chronic Condition Management and Additional Preventive Health Offerings
  6:00 am - Business Wire


• DaVita Clinical Research to Present Research Results on Hospital Readmissions, Anemia Management, Nutrition
  6:00 am - Business Wire


• Dotmatics to Highlight Collaborative Mobile Data Sharing Platform at BioIT World
  6:00 am - Business Wire


• InVivo Therapeutics Receives Humanitarian Use Device Designation for Spinal Cord Injury Treatment
  6:00 am - Business Wire


• Vital Therapies, Inc. Enrolls First Patient in VTI-208, a Controlled, Randomized Phase 3 Trial Evaluating the ELAD(R) System in Alcohol-Induced Liver Decompensation
  6:00 am - Marketwire


• IDT Ltd Appoints Dr. Paul MacLeman CEO
  6:00 am - Marketwire


• Research and Markets: Liver Cancer - Pipeline Review, H1 2013
  5:59 am - Business Wire


• Research and Markets: Pulmonary Hypertension - Pipeline Review, H1 2013
  5:59 am - Business Wire


• Research and Markets: Otitis Media - Pipeline Review, H1 2013
  5:49 am - Business Wire


• North American Injectable Drug Delivery Market worth $16.6 Billion by 2017
  5:30 am - PR Newswire


• Aragon Announces First Patient Dosed in Phase I Study of ARN-810 in Estrogen Receptor Positive Breast Cancer
  5:15 am - Marketwire


• Washington DC Plastic Surgeon on How to Look and Feel Young in One's 50s
  5:05 am - Marketwire


• Hillsborough Cosmetic Dentist Offers Custom Anchored Dentures
  5:03 am - Marketwire


• ACE Launches Life Science Insurance Cover in Continental Europe
  5:03 am - Business Wire


• Knoxville Bariatric Surgeons on How to Alleviate Anxiety About Weight Loss Surgery
  5:01 am - Marketwire


• NPG to Launch Scientific Data to Help Scientists Publish and Reuse Research Data
  4:30 am - PR Newswire


• Generics and Biosimilars in Central and Eastern Europe 25-26 June - Warsaw, Poland
  4:00 am - PR Newswire


• Medivir: Annual Report 2012
  3:14 am - Business Wire


• Market Research Report -- 2,100% Growth for the Cord Blood Banking Industry From 2005 to 2013
  3:08 am - Marketwire


• Notice of Annual General Meeting of Medivir AB (publ)
  3:08 am - Business Wire


• BioInvent Presents Positive Data for BI-505 at International Myeloma Congress
  3:01 am - Business Wire


• New Therapy for Wet AMD Introduced in Switzerland by Oraya® Therapeutics and EyeRAD
  3:00 am - Business Wire


• BioInvent Presents Positive Data for BI-505 at International Myeloma Congress
  2:38 am - Business Wire


• Aerocrine Passes Regulatory Milestone in Japan
  2:19 am - Business Wire


• Aerocrine: Aerocrine’s FeNO Test Now Covered by Georgia Medicaid
  2:12 am - Business Wire


• Dr. Reddy’s Announces the Launch of Zoledronic Acid Injection
  1:55 am - Business Wire


• iovera Introduced in Europe as the World's First Toxin-Free Treatment for Dynamic Facial Lines
  12:00 am - GlobeNewswire